Skip to main content
Loading market data...
ETF Nasdaq USD

Invesco Nasdaq Biotechnology ETF IBBQ

Issuer: Invesco SEC registrant: Invesco Exchange-Traded Fund Trust II Equity · Global
Last price 35.07 USD Change: Up +1.07 Percent change: Up +3.13%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.19%
Prospectus 19 Dec 2025
Net assets
$67.4M
As of 31 May 2026
Holdings
261
As of 31 May 2026
12-month distribution yield
1.12%
Quarterly
Asset class
Equity
From holdings

Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund listed on the Nasdaq in the United States, issued by Invesco. Its category is Equity · Global (equity). Its last price was US$35.07 on 20 Oct 2026. Its expense ratio is 0.19% a year, from its prospectus dated 19 Dec 2025. It reported net assets of US$67.37 million as of 31 May 2026. Its latest holdings report lists 261 holdings as of 31 May 2026. Over the last 12 months it paid distributions of US$0.39 a unit, a 12-month distribution yield of 1.12%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.19%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.19%
Prospectus date
19 Dec 2025
Filed with the SEC
18 Dec 2025

Size and reporting

Net assets
$67,373,541
Total assets
$80,645,249
Holdings as of
31 May 2026
Report made public
28 Jul 2026 (58 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 261 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.

IBBQ top holdings as of 31 May 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Invesco Private Prime Fund No identifier reported 14.20% $9.6M Short-term investment vehicles (cash funds) United States USD
2 Gilead Sciences, Inc. US3755581036 7.39% $5.0M Equity (common) United States USD
3 Vertex Pharmaceuticals Inc. US92532F1003 7.38% $5.0M Equity (common) United States USD
4 Amgen Inc. US0311621009 7.10% $4.8M Equity (common) United States USD
5 Invesco Private Government Fund No identifier reported 5.48% $3.7M Short-term investment vehicles (cash funds) United States USD
6 Regeneron Pharmaceuticals, Inc. US75886F1075 5.08% $3.4M Equity (common) United States USD
7 Alnylam Pharmaceuticals, Inc. US02043Q1076 3.19% $2.1M Equity (common) United States USD
8 Revolution Medicines, Inc. US76155X1000 2.48% $1.7M Equity (common) United States USD
9 Biogen Inc. US09062X1037 2.29% $1.5M Equity (common) United States USD
10 Illumina, Inc. US4523271090 1.98% $1.3M Equity (common) United States USD
11 United Therapeutics Corp. US91307C1027 1.94% $1.3M Equity (common) United States USD
12 Royalty Pharma PLC Royalty Pharma PLC, Class A GB00BMVP7Y09 1.90% $1.3M Equity (common) United Kingdom USD
13 argenx SE argenx SE, ADR US04016X1019 1.89% $1.3M Equity (common) Netherlands USD
14 Insmed Inc. US4576693075 1.83% $1.2M Equity (common) United States USD
15 Roivant Sciences Ltd. BMG762791017 1.71% $1.2M Equity (common) Bermuda USD
16 Incyte Corp. US45337C1027 1.53% $1.0M Equity (common) United States USD
17 Viatris Inc. US92556V1061 1.49% $1.0M Equity (common) United States USD
18 Moderna, Inc. US60770K1079 1.48% $999K Equity (common) United States USD
19 Guardant Health, Inc. US40131M1099 1.35% $912K Equity (common) United States USD
20 Neurocrine Biosciences, Inc. US64125C1099 1.26% $852K Equity (common) United States USD
21 Jazz Pharmaceuticals PLC IE00B4Q5ZN47 1.16% $780K Equity (common) Ireland USD
22 Ascendis Pharma A/S DK0060615755 1.10% $740K Equity (common) Denmark USD
23 Summit Therapeutics Inc. US86627T1088 1.08% $729K Equity (common) United States USD
24 Exelixis, Inc. US30161Q1040 1.04% $703K Equity (common) United States USD
25 BridgeBio Pharma, Inc. US10806X1028 1.02% $689K Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.87%
Short-term investment vehicles (cash funds) 19.69%

Country

Country by weight
CountryWeightBar
United States 103.75%
United Kingdom 2.73%
Netherlands 2.49%
Ireland 1.88%
Bermuda 1.71%
France 1.50%
Denmark 1.23%
Switzerland 1.18%
Canada 0.93%
Germany 0.87%
Cayman Islands 0.64%
Jersey 0.15%
Other (6) 0.50%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 119.56%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 79.50%
Health Technology 1.33%
Technology 0.70%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.3910
4 payments per unit
12-month yield
1.12%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
21 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.3910) ÷ latest price ($35.07) × 100 = 1.12%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (20 payments)
IBBQ distributions per unit by ex-date
Ex-dateAmount per unit
21 Sep 2026$0.2300
22 Jun 2026$0.0340
23 Mar 2026$0.0360
22 Dec 2025$0.0910
22 Sep 2025$0.0960
23 Jun 2025$0.0290
24 Mar 2025$0.0400
23 Dec 2024$0.0620
23 Sep 2024$0.0890
24 Jun 2024$0.0510
18 Mar 2024$0.0440
18 Dec 2023$0.0530
18 Sep 2023$0.0410
20 Jun 2023$0.0450
20 Mar 2023$0.0380
19 Dec 2022$0.0420
19 Sep 2022$0.0380
21 Jun 2022$0.0430
21 Mar 2022$0.0380
20 Dec 2021$0.1050

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme